| HOME >> MEDICINE >> TECHNOLOGY |
US, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Markets for Years 2003, 2010 & 2017 (includes
corresponding Graph/Chart) 79
Table 27: World 15-Year Perspective for Drug Eluting Stents by
Geographic Region - Percentage Breakdown of Unit Sales for US,
Japan, Europe, Asia-Pacific (Excluding Japan) and Rest of
World Markets for Years 2003, 2010 & 2017 (includes
corresponding Graph/Chart) 80
13. THE UNITED STATES 81
A.Market Analysis 81
Largest Market Worldwide 81
Coronary Artery Disease - A US Perspective 81
Baby Boomers Boost Coronary Stent Market 81
Revival in the DES Market 81
Reimbursement System 82
National Average Medicare Payment For DRGS 82
Competitive Scenario 82
Leading Players 82
Coronary Stents - Boston Scientific and JNJ Battle for
Dominance 82
Table 28: Leading Players in the US Coronary Stents
Market (2010) - Percentage Breakdown of Share for Boston
Scientific, Abbott and Johnson & Johnson (includes
corresponding Graph/Chart) 83
Drug Eluting Stents - Competition in the Brewing 83
Table 29: Leading Players in the US Drug-Eluting Stents
Market (2010) - Percentage Breakdown of share for Boston
Scientific, Abbott Labs, J&J-Cordis and Medtronic
(includes corresponding Graph/Chart) 83
Regulatory Environment 84
B.Market Analytics 84
Table 30: US Recent Past, Current & Future Analysis for
Coronary Stents by Product Segment - Bare Metal and Drug
Eluting Stent Markets Independently Analyzed with Annual
Sales in US$ Million for years 2009 through 2017 (includes
corresponding Graph/Chart) 84
Table 31: US Recent Past, Current & Future Analysis for
Coronary Stents by Product Segment - Bare Metal and Drug
El
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |